Literature DB >> 1417955

Rapid chloroquine efflux phenotype in both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. A correlation of chloroquine sensitivity with energy-dependent drug accumulation.

P G Bray1, R E Howells, G Y Ritchie, S A Ward.   

Abstract

Recent reports suggest that lower levels of chloroquine accumulation in chloroquine-resistant isolates of Plasmodium falciparum are achieved by energy-dependent chloroquine efflux from resistant parasites. In support of this argument, a rapid chloroquine efflux phenotype has been observed in some chloroquine-resistant isolates of P. falciparum. In this study, no relationship was found between chloroquine sensitivity and the rate of [3H]chloroquine efflux from four isolates of P. falciparum with a greater than 10-fold range in sensitivity to chloroquine. All the isolates tested displayed the rapid efflux phenotype, irrespective of sensitivity. However, chloroquine sensitivity of these isolates was correlated with energy-dependent rate of drug accumulation into these parasites. Verapamil and a variety of other compounds reverse chloroquine resistance. The reversal mechanism is assumed to result from competition between verapamil and chloroquine for efflux protein translocation sites, thus causing an increase in steady-state accumulation of chloroquine and hence a return to sensitivity. Verapamil accumulation at a steady-state is increased by chloroquine, possibly indicating competition for efflux of the two substrates. Increases in steady-state verapamil concentrations caused by chloroquine were identical in sensitive and resistant strains, suggesting that similar capacity efflux pumps may exist in these isolates. These data suggest that differences in steady-state chloroquine accumulation seen in these isolates can be attributed to changes in the chloroquine concentrating mechanism rather than the efflux pump. It seems likely that chloroquine resistance generally in P. falciparum, results at least in part from a change in the drug concentrating mechanism and that changes in efflux rates per se are insufficient to explain chloroquine resistance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417955     DOI: 10.1016/0006-2952(92)90532-n

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  20 in total

1.  Role of the neurotransmitter reuptake-blocking activity of antidepressants in reversing chloroquine resistance in vitro in Plasmodium falciparum.

Authors:  D Taylor; J C Walden; A H Robins; P J Smith
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine.

Authors:  A F Cowman; D Galatis; J K Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

3.  Dictyostelium discoideum expresses a malaria chloroquine resistance mechanism upon transfection with mutant, but not wild-type, Plasmodium falciparum transporter PfCRT.

Authors:  Bronwen Naudé; Joseph A Brzostowski; Alan R Kimmel; Thomas E Wellems
Journal:  J Biol Chem       Date:  2005-05-09       Impact factor: 5.157

4.  Deciphering the Resistance-Counteracting Functions of Ferroquine in Plasmodium falciparum-Infected Erythrocytes.

Authors:  Faustine Dubar; Sylvain Bohic; Daniel Dive; Yann Guérardel; Peter Cloetens; Jamal Khalife; Christophe Biot
Journal:  ACS Med Chem Lett       Date:  2012-04-13       Impact factor: 4.345

5.  In vitro antimalarial activity of a new organometallic analog, ferrocene-chloroquine.

Authors:  O Domarle; G Blampain; H Agnaniet; T Nzadiyabi; J Lebibi; J Brocard; L Maciejewski; C Biot; A J Georges; P Millet
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

6.  PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX.

Authors:  Patrick G Bray; Mathirut Mungthin; Ian M Hastings; Giancarlo A Biagini; Dauda K Saidu; Viswanathan Lakshmanan; David J Johnson; Ruth H Hughes; Paul A Stocks; Paul M O'Neill; David A Fidock; David C Warhurst; Stephen A Ward
Journal:  Mol Microbiol       Date:  2006-08-31       Impact factor: 3.501

Review 7.  PfCRT-mediated drug transport in malarial parasites.

Authors:  Paul D Roepe
Journal:  Biochemistry       Date:  2010-12-22       Impact factor: 3.162

8.  Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents.

Authors:  David J Johnson; David A Fidock; Mathirut Mungthin; Viswanathan Lakshmanan; Amar Bir Singh Sidhu; Patrick G Bray; Stephen A Ward
Journal:  Mol Cell       Date:  2004-09-24       Impact factor: 17.970

9.  Antimalarial activity of thiosemicarbazones and purine derived nitriles.

Authors:  Jeremy P Mallari; Wendyam A Guiguemde; R Kiplin Guy
Journal:  Bioorg Med Chem Lett       Date:  2009-05-05       Impact factor: 2.823

10.  On the mechanism of chloroquine resistance in Plasmodium falciparum.

Authors:  Mauro Chinappi; Allegra Via; Paolo Marcatili; Anna Tramontano
Journal:  PLoS One       Date:  2010-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.